Clinical Evidence for SecurePortIV Catheter Securement Adhesive

This technical report presents clinical evidence supporting the use of SecurePortIV® Catheter Securement Adhesive. It includes a comprehensive review of various studies related to peripheral and central vascular access, detailing their findings on the effectiveness of the adhesive in reducing complications such as catheter failure, phlebitis, and central line-associated bloodstream infections (CLABSI). The report outlines multiple observational and randomized controlled trials that demonstrate significant improvements in patient outcomes when using SecurePortIV, including reduced rates of dislodgement and overall therapy failure. Additionally, it discusses recommendations and guidelines from relevant health organizations regarding the use of tissue adhesives in vascular access care. The document also highlights the cost-effectiveness of using SecurePortIV in clinical settings, particularly in pediatric populations, and emphasizes the importance of adhering to updated standards of practice for catheter securement.